APLLTD Neutral to bullish

Alembic Pharma gets EIR from USFDA for Karakhadi facility
The US regulator has also indicated that a compliance verification would be performed during re-inspection of the said facility in the next review cycle, it added.
Fundamental AnalysisTrend Analysis

他のメディア:

免責事項